Neurotechnology company Cognito Therapeutics scores $73M

Mar 23, 2023 · Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 million in a Series B funding round led by FoundersX …

CouponFollow Extension

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

6 days from now

Mar 23, 2023 · Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored $73 million in a Series B funding round led by FoundersX …

mobihealthnews.com

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

6 days from now

Mar 23, 2023 · Originally published by MobiHealthNews on March 23, 2023 Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, scored …

agetech.news

$73
OFF

Cognito Therapeutics Scores $73m Series B - Venture Capital Journal

6 days from now

Mar 22, 2023 · The Series B funding brings Cognito’s total financing raised since inception to $93 million The funding will advance Cognito’s study of its non-invasive neuromodulation device …

venturecapitaljournal.com

$73
OFF

Cognito Collects $73M For Light-and-sound Alzheimer's Therapy

6 days from now

Mar 22, 2023 · Cognito beams up $73M for study of light-and-sound neuromod therapy to treat Alzheimer's By Andrea Park Mar 22, 2023 8:00am

fiercebiotech.com

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

6 days from now

Mar 27, 2023 · The clinical-stage neurotechnology company will use the funds to advance the study of its neuromodulation device. “This funding will accelerate development of Cognito’s …

distilnfo.com

$73
OFF

Cognito Therapeutics Raises $73M In Series B Funding For …

6 days from now

Mar 23, 2023 · Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, has completed a $73M Series B financing round led by …

mpo-mag.com

$73
OFF

Neurotechnology Company Cognito Therapeutics Scores $73M

6 days from now

Apr 3, 2023 · Neurotechnology Company Cognito Therapeutics Scores $73M. Share: April 3, 2023. Cognito Therapeutics, a Massachusetts-based startup developing a wearable device …

distilnfo.com

$73
OFF

Cognito Therapeutics Raises $73M For Non-invasive Neuromod Tech

6 days from now

Mar 22, 2023 · Cognito Therapeutics said the Series B brings its total funds raised since inception to $93 million. In addition to the financing, Cognito Therapeutics announced the appointment …

massdevice.com

$73
OFF

Cognito Raises $73M For Alzheimer’s Treatment Headset

6 days from now

Mar 22, 2023 · Cognito Raises $73M for Alzheimer’s Treatment Headset. It delivers proprietary gamma frequency light and sound stimulation. Medical Design & Development Staff. Mar 22, …

medicaldesigndevelopment.com

100%
OFF

New Jersey High School Football Scores - ScoreStream

6 days from now

Scores, Teams for High School Football. Get real-time scores on your website - Customize your teams, colors and styles - Copy & paste website integration - Mobile responsive design - 100% …

scorestream.com

FAQs about Neurotechnology company Cognito Therapeutics scores $73M Coupon?

Does Cognito therapeutics have a series B financing?

CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. ...

Who is Cognito Therapeutics?

About Cognito Therapeutics Cognito Therapeutics is a clinical-stage neurotechnology company developing disease-modifying therapeutic approaches to treat neurodegenerative disorders. Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. ...

Is Cognito a non-invasive neuromodulation device?

Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. The Company’s lead therapy is currently in a pivotal study in Alzheimer’s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA. ...

Who will join Cognito's Board of directors?

In addition to the financing, Dr. Rick Kuntz, MD, MSc, former Senior Vice President, Chief Medical and Scientific Officer of Medtronic and Helen Liang, Founder & Managing Partner at FoundersX, will join Cognito’s Board of Directors. Dr. ...

Can a non-drug neuromodulation intervention help treat Alzheimer's & Cognito?

“A non-drug neuromodulation intervention has the potential to better address the complex nature of neurodegenerative diseases such as Alzheimer’s and Cognito is well-positioned to be a leader in this new paradigm,” said Helen Liang, Founder & Managing Partner, FoundersX Ventures. ...